(Alliance News) - The UK Chancellor has said it would be "foolish" to stop engaging with China. Rachel Reeves is due to hold talks with the US next week amid efforts to strike a trade deal, which the ...

The US president does not have direct authority to fire Federal Reserve governors, but Trump could initiate a lengthy process to attempt to unseat Powell by proving there was "cause" to do so. Trump ...

Meanwhile in the UK, data from the Office for National Statistics showed the consumer price index rose 2.6% in the 12 months to March, slowing from 2.8% in February and below the 2.7% FXStreet-cited ...

(Alliance News) - MP Evans Group PLC on Wednesday said subsidiary PT Evans Indonesia has agreed to acquire two Indonesian plantation companies, to expand its presence in Indonesia.

BP Marsh & Partners PLC - London-based private equity firm, investing in early-stage financial services businesses - Announces up to GBP2 million share buyback to be run by Singer Capital Markets.

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.

(Alliance News) - London's FTSE 100 ended little changed on Thursday, outperforming European peers, as investors weighed an as expected interest rate cut by the European Central Bank.

(Alliance News) - UK consumer price inflation eased in March, driven by falling fuel and recreation costs, data from the Office for National Statistics showed on Wednesday. The consumer price index ...

RC Fornax said its higher revenue in the first half of the year was generated from contracts with six customers. Four of the customers are in the top 10 suppliers to the Ministry of Defence and one is ...

(Alliance News) - REA Holdings PLC on Thursday reported a swing to profit during 2024 as a result of reduced expenses and higher prices, though noted a decrease in production amid dry weather.

IG says futures indicate the FTSE 100 to open down 54.0 points, 0.7%, on Wednesday. The index of London large-caps closed up 1.4% at 8,249.12 on Tuesday. Sterling was quoted at USD1.3263 early ...

Arexvy, already approved in over 60 countries, was supported by trial data showing safety and immune response in the 50–59 age group. GSK said more than 13 million adults in the US fall into this ...